Welcome. If you're a registered user, please log-in. If not, please sign-up.

Animal Models Conference 2012: Informa Life Sciences' 5th Annual Animal Models for Therapeutic Research 2012 Conference

Animal Models Conference 2012: The INDUSTRY driven conference focusing on increasing the prediction of in vivo models for small and large molecule drug development

Increase the prediction of your animal models by joining us at Informa Life Sciences’ Animal Models for Therapeutic Research conference and speed up drug development through increased correlation to clinical results.

Explore the innovative advances in the developments, validation and application of in vivo models to increase translation into the clinic and enhance drug development from key academic research institutions and leading industry organisations. 

In Vivo topics of interest.....

Learn more about....
*Humanisation of animal models
*Animal models for affective disorders
*Knockout models for parkinsons disease
*New models for age related disease
*Reviewing advances in in-vivo oncology studies

This ‘must-attend’ conference is specifically tailored for all those working within in vivo research from pharmaceutical, biotech and academic research institutions

Those who attended previously include:

  • Senior Scientist
  • Research Scientist
  • Director Pharmacology
  • Head of Non Clinical R&D Department
  • Head of in vivo Imaging
  • Pre-Clinical Research Department
  • Group Leader In-Vivo Pharmacology
  • Head of Pharmacology
  • Chief Scientific Officer
  • Scientific Director
 

Animal Models Conference 2012: In Vivo Testing & Humanisation

Failure to accurately predict outcome in the clinic in animal models can result in dramatic costs and slower drug development for the industry. Increasing the translationability and validation of animal models is essential to ensure successful drug development.Download an agenda to see how this meeting can help select the most efficient model for your research programme. Click here for the agenda.

Expert Speakers Include

  • Dr Antonio Martinez, Head of LAS, GSK, Spain
  • Dr Sandra Verploegen, Sr. Scientist, Genmab, The Netherlands
  • Dr Paul S. Jones, Preclinical Sciences Manager, Cancer Research UK, UK
  • Dr Joerg Heyer,Director Cancer Biology, AVEO Pharmaceuticals Inc, USA
  • Dr. Albert Pinhasov,Head, Department of Molecular Biology & Chairman, Integrative Brain Science Center, Israel
  • Dr Paul K Potter, Programme Leader, Disease Models Discovery, MRC Harwell, UK
  • Dr Markus Koch, Lab Head,Bayer Healthcare, Germany
  • Dr Anil Vaidya,Consultant and Science Advisor, Balsathi, USA
  • Peter Clausing, Council Member, AAALAC International,Germany  

Minipig Masterclass: Effectively Selecting your Non-Rodent Species for Pre-Clinical Safety Evaluations

Pre Conference Workshop: 18th June 2012

A Minipig Masterclass: Effectively Selecting your Non-Rodent Species for Pre-Clinical Safety Evaluations

For two reasons the minipig moves into the limelight of non-rodent species selection: Most importantly, with the minipig there is one more species physiologically close to humans to choose from, accomodating the moral imperative to make science-based species selection. This will favour valid results and serve animal welfare (refinement) as well as enhace human drug safety (cf. Guideline CPMP/SWP/1042/99). Secondly, the new EU animal welfare directive (2010/63/EU) encourages the search for alternative species to the reduce the number of non-human primates used. This workshop aims at the introduction of minipigs as an alternative non-rodent species.

Host: Peter Clausing, JP Berlin, Germany


..

Conference Sponsor

..
..
..
..

Spotlight Sponsors

..
..
..
..

Exhibitors

..
..
..
..

Promotional Participant

..
..
..
..

ANIMAL MODELS 2 Co-located events:

..
..
..

ANIMAL MODELS In Vivo Experts Address Critical Topics Covering:

Humanised Mice Model in Malaria Research Humanisation Strategies to Study Drug Action In Vivo Exploring Animal Models for Affective Disorders Utilising Disease Based Animal Models for Pre-clinical Testing of Biotherapeutics
Regulatory acceptance of alternative animal models Reviewing Stem Cells and Personalised Medicine Exploring Stem Cell Therapy of Liver Diseases Recent studies demonstrated the potential of mesenchymal stem cells derived
Overcoming the Practical Challenges of Species Selection for Efficacy, Safety and Toxicity Assessment of Engineered Monoclonal Antibody-based Biologics

Increased Networking: Animal Models for Therapeutic Research conference is co-located with

7th Annual

Cell Based Assays

Dates to be confirmed


Feeds
rss
Like
Share
twitterfacebooklinkedinemail

Dates and Venues

19 Jun 2012 - 20 Jun 2012

Estrel Hotel, Berlin, Germany

Poll

What Animal Model Are You Working On?

 
 




 

Animal Models Past Conference Reviews

"Useful mixture of topics on current and future animal models, their role in therapeutical research, and some interesting case studies"
Lek Pharmaceuticals
"An interesting and informative conference reviewing current techniques and enhancements in preclinical animal models"
Morphosys AG